Lisa Kay Foster

Title: Lisa Kay Foster: Innovator in Protein Analog Research

Introduction

Lisa Kay Foster is a prominent inventor based in Greenwood, IN (US). She has made significant contributions to the field of protein analogs, holding a total of 2 patents. Her work focuses on innovative processes that enhance the preparation of obesity protein analogs.

Latest Patents

Foster's latest patents include a process for preparing obesity protein analogs. This invention is directed to an improved method for achieving high yields of obesity protein analogs using a dipeptidylaminopeptidase isolated from the slime mold, Dictyostelium discoideum. Another notable patent is a method for removing N-terminal dipeptides from precursor polypeptides. This method involves contacting the precursor polypeptide for a sufficient time to remove the dipeptide with an immobilized dipeptidylaminopeptidase (dDAP) from the same slime mold, which has a mass of about 225 kilodaltons and a pH optimum of about 3.5. The precursor polypeptides may be made recombinantly and can be analogs of naturally occurring polypeptides.

Career Highlights

Lisa Kay Foster is currently associated with Eli Lilly and Company, where she continues to advance her research in protein analogs. Her work has garnered attention for its potential applications in the field of obesity treatment and protein engineering.

Collaborations

Foster has collaborated with notable coworkers such as Paul R Atkinson and Warren C MacKellar, contributing to a dynamic research environment that fosters innovation.

Conclusion

Lisa Kay Foster is a trailblazer in the field of protein analog research, with her patents reflecting her commitment to advancing scientific knowledge and practical applications. Her contributions are poised to make a significant impact in the industry.